Tigecycline for treatment of nosocomial-acquired pneumonia possibly caused by multi-drug resistant strains of Stenotrophomonas maltophilia.
Blanquer
D
D
Pneumology, Hospital de Manacor, Balearic Islands, Spain. davidovichbe03@yahoo.es
De Otero
J
J
Padilla
E
E
Gómez
F
F
Mayol
A
A
Irigaray
R
R
Espejo
P
P
Rada
M A
MA
Makrantoni
G
G
Pérez
A R
AR
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000150:complications; D003428:Cross Infection / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018432:Drug Resistance, Multiple; D004646:Emphysema / Q000150:complications; D016905:Gram-Negative Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000150:complications; D008297:Male; D008911:Minocycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D018410:Pneumonia, Bacterial / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D020615:Stenotrophomonas maltophilia / Q000187:drug effects*; D000078304:Tigecycline; D001749:Urinary Bladder Neoplasms / Q000150:complications
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline